SEC Form 4 · accession 0001203311-17-000092
SEATTLE GENETICS INC /WA · SGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Marc E Lippman
Director
Period of report
Nov 15, 2017
Accepted (ET)
Nov 17, 2017 · 8:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001060736
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Nov 15, 2017 | S | 3,000 | $58.0747 | D | 132,050 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $58.07 to $58.13. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- F2Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.